Atovaquone-d4

Atovaquone-d4
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T19198-1mg 1 mg

7 - 10 business days*

383.00€
TGM-T19198-5mg 5 mg

7 - 10 business days*

1,177.00€
TGM-T19198-10mg 10 mg

7 - 10 business days*

1,923.00€
TGM-T19198-25mg 25 mg

7 - 10 business days*

3,632.00€
 
Description: Atovaquone D4 is the deuterium-labeled Atovaquone. Atovaquone is a medication used... more
Product information "Atovaquone-d4"
Description: Atovaquone D4 is the deuterium-labeled Atovaquone. Atovaquone is a medication used to treat or prevent pneumocystis babesia, malaria, toxoplasmosis, and pneumonia. Smiles: O=C1C(=C(O)C(=O)C=2C1=C(C(=C(C2[2H])[2H])[2H])[2H])[C@H]3CC[C@@H](CC3)C4=CC=C(Cl)C=C4. References: Looareesuwan, S., et al., Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996. 54(1): p. 62-6.
Supplier: TargetMol
Supplier-Nr: T19198

Properties

Application: GC-MS, LC-MS, internal standard, quantification, reversible MAO-B inhibitor
MW: 370.86 D
Formula: C22H19ClO3

Database Information

CAS : 2070015-14-2| Matching products
KEGG ID : K00274 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Atovaquone-d4"
Write a review
or to review a product.
Viewed